FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801398567> ?p ?o ?g. }

• W2801398567 endingPage "190" @default.
• W2801398567 startingPage "179" @default.
• W2801398567 abstract "68Gallium prostate-specific membrane antigen positron emission tomography (68Ga-PSMA PET) is an emerging imaging modality for assessment of prostate cancer. Recent studies show promising results regarding its ability to detect recurrent or metastatic prostate cancer superior to that of conventional imaging modalities. However, the impact of 68Ga-PSMA PET on management of patients with prostate cancer has not been well established. To perform a systematic review and meta-analysis to evaluate the impact of 68Ga-PSMA PET on management of patients with prostate cancer. Pubmed and EMBASE databases were searched up to January 20, 2018. We included studies that reported proportion of management change after 68Ga-PSMA PET in patients with prostate cancer. The quality of the studies was evaluated using the GRADE system. The proportion of management changes were pooled using random-effects model. Subgroup analyses and meta-regression analyses were performed to explore heterogeneity. Fifteen studies (1163 patients) were included. The pooled proportion of management changes was 54% (95% confidence interval 47–60%). At meta-regression analyses, PET positivity (%) was a significant factor of heterogeneity (p = 0.0486). For patients with biochemical failure, the proportion of radiotherapy (from 56% to 61%), surgery (from 1% to 7%), focal therapy (from 1% to 2%), and multimodal treatment (from 2% to 6%) increased, whereas that of systemic treatment (from 26% to 12%) and no treatment (from 14% to 11%) decreased with 68Ga-PSMA PET. 68Ga-PSMA PET had a large impact on the management of patients with prostate cancer. Greater PET positivity was associated with higher proportion of management changes. We reviewed all previous studies assessing the impact of 68Gallium prostate-specific membrane antigen positron emission tomography (68Ga-PSMA PET) in patients with prostate cancer. We found that 68Ga-PSMA PET altered the management in approximately half of the patients." @default.
• W2801398567 created "2018-05-17" @default.
• W2801398567 creator A5024328581 @default.
• W2801398567 creator A5028519882 @default.
• W2801398567 creator A5035052771 @default.
• W2801398567 creator A5046133970 @default.
• W2801398567 date "2018-08-01" @default.
• W2801398567 modified "2023-10-10" @default.
• W2801398567 title "Impact of 68 Ga-PSMA PET on the Management of Patients with Prostate Cancer: A Systematic Review and Meta-analysis" @default.
• W2801398567 cites W1903999661 @default.
• W2801398567 cites W1981680557 @default.
• W2801398567 cites W2002837171 @default.
• W2801398567 cites W2034833060 @default.
• W2801398567 cites W2053554578 @default.
• W2801398567 cites W2104675861 @default.
• W2801398567 cites W2113957566 @default.
• W2801398567 cites W2118081603 @default.
• W2801398567 cites W2123161437 @default.
• W2801398567 cites W2148867458 @default.
• W2801398567 cites W2157823046 @default.
• W2801398567 cites W2161810494 @default.
• W2801398567 cites W2179945673 @default.
• W2801398567 cites W2196246894 @default.
• W2801398567 cites W2211198407 @default.
• W2801398567 cites W2403354006 @default.
• W2801398567 cites W2470255787 @default.
• W2801398567 cites W2511755939 @default.
• W2801398567 cites W2511949746 @default.
• W2801398567 cites W2532226140 @default.
• W2801398567 cites W2540348172 @default.
• W2801398567 cites W2557050169 @default.
• W2801398567 cites W2561039633 @default.
• W2801398567 cites W2576440140 @default.
• W2801398567 cites W2579885790 @default.
• W2801398567 cites W2586386444 @default.
• W2801398567 cites W2598457068 @default.
• W2801398567 cites W2607183624 @default.
• W2801398567 cites W2615655377 @default.
• W2801398567 cites W2736737591 @default.
• W2801398567 cites W2746662560 @default.
• W2801398567 cites W2761935156 @default.
• W2801398567 cites W2766371188 @default.
• W2801398567 cites W2767599185 @default.
• W2801398567 cites W2771847508 @default.
• W2801398567 cites W2775321189 @default.
• W2801398567 cites W2784001077 @default.
• W2801398567 cites W2785565887 @default.
• W2801398567 cites W2917837889 @default.
• W2801398567 doi "https://doi.org/10.1016/j.eururo.2018.03.030" @default.
• W2801398567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29678358" @default.
• W2801398567 hasPublicationYear "2018" @default.
• W2801398567 type Work @default.
• W2801398567 sameAs 2801398567 @default.
• W2801398567 citedByCount "234" @default.
• W2801398567 countsByYear W28013985672018 @default.
• W2801398567 countsByYear W28013985672019 @default.
• W2801398567 countsByYear W28013985672020 @default.
• W2801398567 countsByYear W28013985672021 @default.
• W2801398567 countsByYear W28013985672022 @default.
• W2801398567 countsByYear W28013985672023 @default.
• W2801398567 crossrefType "journal-article" @default.
• W2801398567 hasAuthorship W2801398567A5024328581 @default.
• W2801398567 hasAuthorship W2801398567A5028519882 @default.
• W2801398567 hasAuthorship W2801398567A5035052771 @default.
• W2801398567 hasAuthorship W2801398567A5046133970 @default.
• W2801398567 hasConcept C121608353 @default.
• W2801398567 hasConcept C126322002 @default.
• W2801398567 hasConcept C126838900 @default.
• W2801398567 hasConcept C143998085 @default.
• W2801398567 hasConcept C20417620 @default.
• W2801398567 hasConcept C2775842073 @default.
• W2801398567 hasConcept C2776235491 @default.
• W2801398567 hasConcept C2780192828 @default.
• W2801398567 hasConcept C2781114028 @default.
• W2801398567 hasConcept C44249647 @default.
• W2801398567 hasConcept C509974204 @default.
• W2801398567 hasConcept C71924100 @default.
• W2801398567 hasConcept C95190672 @default.
• W2801398567 hasConceptScore W2801398567C121608353 @default.
• W2801398567 hasConceptScore W2801398567C126322002 @default.
• W2801398567 hasConceptScore W2801398567C126838900 @default.
• W2801398567 hasConceptScore W2801398567C143998085 @default.
• W2801398567 hasConceptScore W2801398567C20417620 @default.
• W2801398567 hasConceptScore W2801398567C2775842073 @default.
• W2801398567 hasConceptScore W2801398567C2776235491 @default.
• W2801398567 hasConceptScore W2801398567C2780192828 @default.
• W2801398567 hasConceptScore W2801398567C2781114028 @default.
• W2801398567 hasConceptScore W2801398567C44249647 @default.
• W2801398567 hasConceptScore W2801398567C509974204 @default.
• W2801398567 hasConceptScore W2801398567C71924100 @default.
• W2801398567 hasConceptScore W2801398567C95190672 @default.
• W2801398567 hasIssue "2" @default.
• W2801398567 hasLocation W28013985671 @default.
• W2801398567 hasOpenAccess W2801398567 @default.
• W2801398567 hasPrimaryLocation W28013985671 @default.
• W2801398567 hasRelatedWork W2075763133 @default.
• W2801398567 hasRelatedWork W2088520467 @default.
• W2801398567 hasRelatedWork W2376423713 @default.

• next